
ex-CEO, Sage Therapeutics @sagebiotech, ex-President Alnylam
Cambridge, MA
Joined December 2008
- Tweets515
- Following154
- Followers1.5K
- Likes3.8K
Barry Greene retweeted
A week later, and this is what you come up with? This is a despicable statement, Congressman-elect.
I’m reminded of December 2023, when Ivy League presidents said calling for violence against Jews is only wrong depending on the context. Here, you justify this deliberate targeting of Jewish businesses because “let’s not forget how we got here.”
Harassing business owners because they are Jewish is gross and wrong—period. No ifs, ands, or buts. It’s not hard.
Remarkable - Us innovation
🚨#BREAKING: SpaceX has CAUGHT Starship with the launch tower for the FIRST TIME EVER!!!
After 14 orbits and 22+ hours in space, Ship 42 came home and the chopsticks grabbed it right out of the sky.
History. 🇺🇸
1
71
Barry Greene retweeted
Conditional or “dramatic changes” to military support for Israel — without disarming Hamas — only strengthen Hamas.
This vote and voice will always follow our special ally.
Barry Greene retweeted
Elebsiran (aka, ALN-HBV02, VIR-2218) has a special place in the development of RNAi Rx.
Championed by our scientists @LauraSepplore and @VasantRJadhav, it’s protype molecule (ALN-HBV01) showed dose dependent LFT elevations, which would have seriously impaired clinical viability in a diseased liver setting like HBV/HDV.
These findings led to the development of our “ESC+” platform that included destabilization of the guide strand seed sequence to attenuate RISC-mediated off target effects.
If approved, Elebsiran will be the first ESC+ GalNAc-siRNA to reach the market!
Very exciting result for RNAi!
Following NDA submission and FDA approval, Elebsiran is now positioned to be the 10th approved RNAi brought to market!
Cemdisiran for myasthenia gravis is currently in queue for #9.
Exciting times ahead!
Barry Greene retweeted
Over the weekend, I traveled to Berlin with a delegation of constituents to commemorate the 88th anniversary of Kristallnacht, the Nazi-organized pogrom that saw the widespread destruction of Jewish businesses and synagogues, foreshadowing the horrors of the Holocaust.
I never imagined returning to America to discover that, during the same week as Kristallnacht’s anniversary, extremists had organized a boycott of Jewish businesses, declaring, “These Zionist establishments must go.”
We are unlearning the lessons of history at great peril not only to our Jewish brothers and sisters but also to ourselves.
Barry Greene retweeted
When @JDVance says that two of the major reasons for the anti-Republican tsunami are the Iran War and the Trump Administration’s relationship with Israel, he’s actually conceding his own failure and placing the blame on himself.
The rationale for the Iran War was to prevent a rogue terror state from acquiring a nuclear weapon. No American, properly informed, would oppose such an essential action to protect American citizens. But JD did not support the President in this core exercise of executive power, and even garbled the message by saying it was all about the price of gas (an incoherent justification insofar as gas was not expensive before the war). So if Republicans do not support the war, JD should look no further than a mirror.
As to Israel, it was the only country to risk its blood and treasure in support of America’s self defense. Israel didn’t and couldn’t force America into this war — it alone came to America’s aid. But JD, instead of leading on this issue, succumbs to the all too convenient “blame Israel” crowd that he has never disavowed.
If Republicans are to recover from this shellacking, a sober assessment of its mistakes is essential. In my view, that begins with the recognition that on a core and necessary exercise of presidential power, the vice president was off the reservation.
Barry Greene retweeted
I refuse to believe that ordinary Philadelphians are going to tolerate this blatantly antisemitic bullshit.
Barry Greene retweeted
We’re excited to announce the pricing of our upsized initial public offering at $18.00 per share, for gross proceeds of approximately $200.0 million. City will trade on Nasdaq under the ticker $CTY.
Read more: investors.citytx.com/news-re…
Sad but True - myths and lies got a Noble
It used to be you got ostracized for antisemitism. Now you win the Nobel Peace Prize for it. timesofisrael.com/navi-pilla…
1
177



















